MG INTERNATIONAL overview

Lannett Announces Approval For Metaxalone Tablets USP, 800 Mg PR Newswire PHILADELPHIA, Nov. 28, 2016 PHILADELPHIA , Nov. 28, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Metaxalone Tablets USP, 800 mg, the therapeutic equivalent to the reference listed drug, Skelaxin ® of King Pharmaceuticals, Inc. According to IMS, total U.S. sales for the 12...

Lannett Announces Approval For Memantine Hydrochloride Tablets USP, 5 mg And 10 mg PR Newswire PHILADELPHIA, Nov. 14, 2016 PHILADELPHIA , Nov. 14, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, the therapeutic equivalent to the reference listed drug, Namenda Tablets, 5 mg and 10 mg, of Forest...

Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg PR Newswire PHILADELPHIA, Sept. 20, 2016 PHILADELPHIA , Sept. 20, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the therapeutic equivalent to the reference listed drug,...

Deloitte loses appeal in MG Rover disciplinary case Accounting firm Deloitte has lost its appeal against a regulatory ruling that it failed to manage conflicts of ......